Open AccessVery rare near‐haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR‐T therapy in 19‐year‐old male patient
Author(s) -
Arpas Tomas,
Jelinkova Hana,
Hrabovsky Stepan,
Orsulova Martina,
Vrzalova Zuzana,
Navrkalova Veronika,
Brhelova Eva,
Bryjova Lenka,
Bulikova Alena,
Ondrouskova Eva,
Sejnohova Marketa,
Folber Frantisek,
Sedová Petra,
Mayer Jiri,
Pospisilova Sarka,
Jarosova Marie,
Doubek Michael
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5545
Subject(s) - medicine , lymphoblastic leukemia , immunotherapy , monoclonal antibody , disease , immunology , antibody , oncology , leukemia , cancer
Abstract Near‐haploid acute lymphoblastic leukemia is rare subgroup of the disease, which is very important due to very poor prognosis and resistance to treatment including novel monoclonal antibodies and CAR‐T therapy.